obtain
potenti
antivir
agent
special
featur
spatial
structur
one
exampl
synthes
compound
studi
result
given
investig
cytotox
antivir
activ
relat
type
herp
viru
coronaviru
known
erupt
chickenpox
adult
also
caus
shingl
manifest
discharg
stomach
chest
accompani
pain
compar
oncolog
epsteinbarr
viru
type
caus
infecti
mononucleosi
cytomegaloviru
littl
studi
present
herp
type
affect
nervou
system
human
intern
organ
etiolog
link
without
basi
propos
herp
type
enceph
type
chronic
fatigu
syndrom
call
mass
inform
media
plagu
st
centuri
kaposi
sarcoma
associ
hiv
infect
aid
also
caus
herp
viru
type
proceed
control
widespread
numer
herpesvir
ill
one
import
problem
contemporari
medic
scienc
although
list
chemic
prepar
effect
suppress
variou
stage
reproduct
herp
viru
fairli
broad
medicin
prophylact
effect
satisfi
practic
public
health
reason
epidem
spread
herp
viru
infect
world
steadili
continu
search
antiherpet
agent
differ
mechan
action
lost
urgenc
continu
investig
search
new
biolog
activ
substanc
among
deriv
heterocycl
system
relat
present
commun
devot
nramid
acid
compound
chosen
us
subject
investig
basi
preliminari
prognosi
carri
pass
program
show
fairli
high
less
probabl
display
antiherp
properti
solubl
water
import
characterist
potenti
antivir
agent
substanti
facilit
studi
view
limit
circl
substanc
investig
dialkylaminoalkylamid
sinc
necessari
may
alway
readili
convert
watersolubl
quaternari
ammonium
salt
miner
acid
j
q
j
j
q
j
desir
compound
tabl
obtain
amid
ethyl
ester
correspond
acid
excess
dialkylaminoalkylamin
boil
ethanol
colorless
crystallin
substanc
readili
solubl
alcohol
practic
insolubl
ether
moder
solubl
dialkylaminoalkylamid
water
enabl
studi
antivir
properti
carri
without
convers
salt
structur
synthes
substanc
confirm
h
nmr
spectra
tabl
structur
one
compound
amid
investig
detail
manner
xray
structur
analysi
fig
tabl
establish
nonhydrogen
atom
pyridinopyrimidin
bicycl
also
c
n
c
c
atom
lie
one
plane
precis
probabl
caus
presenc
two
strong
intramolecular
hydrogen
bond
h
n
h
format
indic
hydrogen
bond
lead
signific
redistribut
electron
densiti
pyrimidon
fragment
c
c
pyridin
fragment
amid
tendenc
observ
toward
local
bond
bond
length
c
c
c
c
significantli
shorten
bond
c
c
c
c
lengthen
analog
effect
also
note
pyridopyrimidin
c
atom
found
apconform
rel
c
n
bond
torsion
angl
c
n
c
c
n
atom
pyramid
configur
sum
valenc
angl
centr
nitrogen
atom
found
scconform
rel
n
c
bond
torsion
angl
n
c
c
n
c
c
ethyl
substitu
occupi
posit
intermedi
acand
aprconform
c
c
ethyl
substitu
found
scconform
rel
c
c
bond
torsion
angl
c
n
c
c
c
n
c
c
c
atom
orient
close
sc
c
orient
close
ap
rel
c
n
bond
torsion
angl
c
n
c
c
c
n
c
c
posit
ethyl
group
lead
shorten
intramolecular
contact
h
creation
effect
safe
antivir
prepar
one
complex
problem
contemporari
pharmaceut
chemistri
medicin
complex
consist
need
develop
substanc
capabl
select
repress
reproduct
viru
without
affect
activ
life
cell
host
organ
first
step
biolog
test
amid
determin
cytotox
cultur
transplant
calf
embryo
kidney
cell
ck
calf
coronari
vessel
ccv
use
turn
concentr
toxic
effect
record
major
amid
even
second
day
appear
individu
degener
cell
background
incipi
destruct
cell
monolay
fifth
day
sign
cytotox
action
intensifi
even
signific
destruct
monolay
cell
observ
appear
conglomer
degener
cell
round
form
granular
cytoplasm
tear
away
glass
surfac
major
case
cytotox
assess
destruct
cell
monolay
final
complet
degener
almost
cell
set
day
cultiv
control
cell
cultur
ck
ccv
still
display
viabil
time
although
appear
also
observ
individu
degen
cell
background
incipi
destruct
cell
monolay
follow
experi
carri
concentr
amid
show
neg
effect
morpholog
cultur
ck
ccv
cell
due
express
toxic
use
carri
investig
nonetheless
concentr
amid
prove
less
toxic
exampl
e
f
h
first
day
observ
display
insignific
sign
cytotox
action
substanti
injuri
cell
cell
monolay
note
toward
end
five
day
studi
deriv
acid
two
substanc
amid
concentr
gener
show
cytotox
action
stretch
sever
day
toward
fifth
day
observ
first
sign
toxic
injuri
display
howev
toward
time
analog
chang
also
note
control
cell
cultur
basi
investig
carri
may
therefor
state
one
main
criteria
taken
consider
select
substanc
potenti
antivir
activ
viz
absenc
effect
cell
macroorgan
fulfil
aqueou
solut
amid
pass
follow
stage
screen
type
herp
simplex
viru
contain
dna
one
widespread
herpesvirida
famili
led
select
testviru
us
strain
use
us
isol
patient
clinic
express
form
acut
herp
viral
infect
obtain
viru
collect
ivanovskii
institut
virolog
russian
academi
medic
scienc
moscow
russia
restor
infecti
activ
strain
underw
three
passag
cell
cultur
antiherp
activ
amid
studi
neutral
reaction
cultur
transplant
ck
ccv
cell
allow
cytopath
action
display
basi
investig
carri
us
must
said
data
comput
prognosi
expedi
test
amid
deriv
acid
presenc
antivir
activ
fact
confirm
investig
substanc
prove
capabl
significantli
inhibit
reproduct
amid
log
amid
log
circumst
enabl
activ
compound
acid
recommend
depth
studi
includ
experi
vivo
potenti
antiherp
agent
sever
year
ago
whole
world
alarm
outbreak
seriou
respiratori
ill
accompani
high
mortal
call
atyp
pneumonia
sar
sever
acut
respiratori
syndrom
origin
coronaviru
one
import
repres
rnacontain
virus
spite
whole
intens
investig
undertaken
search
effect
anticoronaviru
drug
regrett
yet
crown
success
still
urgent
consid
amid
display
antivir
activ
relat
test
us
possibl
inhibitor
hemagglutin
activ
coronavirus
establish
amid
show
signific
effect
viabil
coronaviru
consequ
investig
direct
unpromis
structur
solv
direct
method
shelxtl
set
program
posit
hydrogen
atom
made
appar
electron
densiti
differ
synthesi
refin
isotrop
structur
refin
f
full
matrix
least
squar
method
anisotrop
approach
nonhydrogen
atom
wr
reflect
r
reflect
f
f
full
crystallograph
inform
deposit
cambridg
crystal
databas
ccdc
interatom
distanc
valenc
angl
given
tabl
cytotox
determin
transplant
cell
calf
embryo
kidney
incub
medium
ad
bovin
serum
cell
calf
coronari
vessel
medium
consist
equal
volum
eagl
medium
medium
content
bovin
serum
prevent
possibl
bacteri
contamin
nutrient
media
antibiot
penicillin
streptomycin
ad
carri
experiment
investig
type
cell
cultur
thermostat
c
medium
ph
day
growth
medium
remov
test
tube
aqueou
solut
ml
amid
test
concentr
support
nutrient
medium
ml
introduc
form
monolay
cultur
cell
test
tube
specimen
concentr
incub
c
observ
day
test
tube
cell
cultur
without
addit
substanc
studi
serv
control
cytotox
determin
examin
microscop
low
magnif
disturb
monolay
chang
morpholog
cell
round
shrivel
tear
away
degener
cell
glass
surfac
determin
antiherp
activ
suspens
ml
contain
work
dose
cpd
ml
cytopath
dose
viru
caus
diseas
cell
monolay
ad
aqueou
solut
ml
compound
studi
result
mixtur
incub
room
temperatur
min
obtain
mixtur
ml
introduc
test
tube
cultur
cell
support
nutrient
medium
ml
conta
serum
antivir
inhibitor
possibl
present
ad
way
actual
concentr
amid
test
cell
cultur
without
addit
test
viru
cell
infect
oper
dose
without
chemic
substanc
test
use
control
incub
c
day
morpholog
chang
cell
monolay
cytopath
effect
viru
record
viru
titer
presenc
test
compound
control
calcul
log
cpd
criterion
antivir
action
calcul
presenc
differ
viru
titer
comparison
control
valu
determin
effect
coronaviru
strain
kharkov
use
experi
obtain
institut
experiment
clinic
veterinari
medicin
kharkov
ukrain
check
viabil
carri
experi
studi
antivir
activ
amid
relat
coronaviru
carri
hemagglutin
inhibit
reaction
equal
volum
coronaviru
suspens
oper
dose
hemagglutin
unit
chemic
substanc
aqueou
solut
show
cytotox
action
mix
incub
min
room
temperatur
degre
inhibit
hemagglutin
activ
coronaviru
determin
coronaviru
indic
oper
dose
mous
erythrocyt
prepar
physiolog
solut
ph
concentr
use
control
